Results 181 to 189 of about 10,551 (189)

Inconsistencies in the association between the JAK2^V617F mutation and PRV‐1 over‐expression among the chronic myeloproliferative diseases

British Journal of Haematology, 2006
Inconsistencies in the association between the JAK2(V617F) mutation and PRV-1 over-expression among the chronic myeloproliferative diseases.
VANNUCCHI, ALESSANDRO MARIA, GUGLIELMELLI, PAOLA, ANTONIOLI, ELISABETTA, MAPPA, SILVIA, PANCRAZZI, ALESSANDRO, BOGANI, COSTANZA, PONZIANI, VANESSA, BOSI, ALBERTO   +7 more
openaire   +2 more sources

The Clinical and PRV-1 Expression Phenotype of Wild-Type, Heterozygous, and Homozygous JAK2 V617F in Polycythemia Vera.

Blood, 2005
Abstract BACKGROUND. Several studies have recently reported on the occurrence of a JAK2 V617F mutation in myeloid cells from the majority of patients with polycythemia vera (PV). The clinical relevance of this novel observation is currently under study.
D. Gary Gilliland, Stephanie J. Lee, Martha Wadleigh, Chin Yang Li, David P. Steensma, Alexandra P. Wolanskyj, Ruben A. Mesa, Michelle A. Elliott, Jacob S. Strand, Susan M. Schwager, Terra L. Lasho, Shireen Sirhan, Ayalew Tefferi   +12 more
openaire   +1 more source

PRV-1 mRNA expression and other molecular markers in polycythemia rubra vera.

Current hematology reports, 2003
During the past 4 years, the first molecular markers for polycythemia vera (PV) have been described. These markers include decreased expression of the thrombopoietin receptor c-Mpl, increased expression of the surface receptor polycythemia rubra vera-I, and insulin-like growth factor-I hypersensitivity.
openaire   +1 more source

Characterization of PRV-1, a Novel Hematopoietic Cell Surface Marker Overexpressed in Polycythemia Rubra Vera

2004
While the pathognomonic mutation causing chronic myeloid leukemia (CML), the “Philadelphia chromosome”, is well characterized, and the detection of the bcr/abl fusion transcript, allows a precise, molecular diagnosis of CML, to date there is no characteristic molecular marker for the diagnosis of polycythemia vera (PV).
openaire   +1 more source

Sequence Analysis of PRV-1 Isolates Pre- and Post-emergence of HSMI

2022
Yrjönheikki, Anneli Siiri, Carlsson, Thea, Edvardsen, Anette, Vatne, Nina Askim, Wessel, Øystein, Rimstad, Espen   +5 more
openaire   +1 more source

Concomitant neutrophil JAK2 mutation screening and PRV-1 expression analysis in myeloproliferative disorders and secondary polycythaemia.

British journal of haematology, 2005
Polycythaemia vera (PV) is closely associated with both an acquired activating mutation of the JAK2 tyrosine kinase (JAK2(V617F)) in granulocyte-derived DNA and increased granulocyte polycythaemia rubra vera-1 (PRV-1) expression. In order to explore the correlation between these two biological markers and compare their diagnostic utility, mutation ...
Ayalew, Tefferi, Shireen, Sirhan, Terra L, Lasho, Susan M, Schwager, Chin-Yang, Li, David, Dingli, Alexandra P, Wolanskyj, David P, Steensma, Ruben, Mesa, D G, Gilliland   +9 more
openaire   +1 more source

Fluorescence in situ hybridization analysis of the PRV-1 gene in polycythemia vera

Experimental Hematology, 2003
Vesna Najfeld, Shai Fuchs, Paul Merando, Kimberly Lezon-Geyda, Steven Fruchtman   +4 more
openaire   +1 more source

Asymptomatic PRV-1 infection in Atlantic salmon triggers spleen specific Th1 immune response

Fish & Shellfish Immunology
Eva Vallejos-Vidal, Fernanda Espinoza-Vega, Laura V. Solarte-Murillo, María J. Santillán-Araneda, Sebastián Reyes-Cerpa, Daniela Toro-Ascuy, Kevin Maisey, Mónica Imarai, Ana María Sandino, Felipe E. Reyes-Lopez   +9 more
openaire   +1 more source

Immune profiling in asymptomatic Atlantic salmon (Salmo salar L.) naturally infected with Orthoreovirus piscis-1 (PRV-1)

Fish & Shellfish Immunology
Fernanda Espinoza-Vega, Laura V. Solarte-Murillo, María J. Santillán-Araneda, Sebastián Reyes-Cerpa, Daniela Toro-Ascuy, Kevin Maisey, Mónica Imarai, Ana María Sandino, Felipe E. Reyes-Lopez, Eva Vallejos-Vidal   +9 more
openaire   +1 more source